Fingerprint
Dive into the research topics of 'A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically